We have described the synthesis and biological activity of novel retinamide derivatives. The retinamide derivatives were synthesized by introducing functional side chains into the 4-hydroxy group of 4-HPR. The activities could be dependent on the side chain length, functional group, and hetero atom. The antiproliferative potential of the derivatives was assessed by MTT assay in HCT116 colon cancer cell lines.
Introduction
Retinoids are natural and synthetic analogues of vitamin A that are involved in the regulation of several biological functions such as cellular differentiation and proliferation. Clinically, retinoids are useful for the treatment of skin disorders and cancer 1 and are currently being investigated in several other therapeutic areas, including arthritis, 2 dyslipidemias, 3 and the prevention of HIV induced lymphopenia. 4 All-trans retinoic acid (RA) and its amide derivative, N-(4-hydroxyphenyl)retinamide (4-HPR) were synthesized years ago and found to be effective against various skin diseases and are now being considered as potential drugs for treatment and prevention of several cancers. 5, 6 Though 4-HPR is derived from the natural retinoid, retinoic acid, it is less toxic and substantially less teratogenic than RA. 7 Additionally, the lower toxicity of retinamide has led to its experimental use in animal studies as an antitumor agent 8 and in clinical trials as a chemopreventive agent for breast cancer. 9 4-HPR displays antiproliferative effects in vitro against human breast carcinoma cells 5 and induces apoptosis in the hemopoietic cell line. 10 A recent study suggests that 4-HPR is a highly selective activator of the retinoic acid receptor γ (RAR γ), 9 inhibits AP-1 activity, and induces apoptosis in ovarian cancer cells. 11 Also it has been reported that some 4-HPR derivatives show greater efficacy and less toxicity than original 4-HPR when tested in a culture of breast carcinoma cells. 12 Furthermore, the chemopreventive potential of 4-HPR has been determined against the development and growth of 7,12-dimethylbenzanthracene (DMBA)-induced rat mammary tumor.
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Results and Discussion
In the present study, we describe the synthesis and biological activity of the retinamide derivatives. The derivatives were synthesized by introducing functional side chains into the 4-hydroxy group of HPR ( Figure 2 ). The antiproliferative potential of the derivatives was determined by MTT in HCT116 colon cancer cell lines.
Various conjugates of 4-HPR have been prepared in two steps as described in Schemes 1 and 2. The preparation of 4-HPR derivatives (Figure 2 ) consisted of the general Oacylation of 4-HPR with various alkanoic acids, sulfonyl chlorides and phosphoryl chlorides.
As shown in Scheme 1, all-trans retinoic acid (RA) was converted into an acid chloride derivative using SOCl 2 and dimethylformamide (DMF), and then coupled with p-aminophenol to obtain 4-HPR by a procedure recently described. 14, 15 The synthesis of retinamide derivatives was carried out as follows. First, derivatives 1-5 were prepared by the coupling of various alkanoic acids and 4-HPR, under the conditions employing EDCI/DMAP at room temperature in dry DMF. α-Keto form 1 and 2 were obtained in low yields, due to decomposition upon purification. Second, derivatives 6 and 7 were synthesized from the reaction of 4-HPR and alkane sulfonyl chlorides in presence of N-methylmorpholine (NMM) in dry CH2Cl2.
As in Scheme 2, treating the requisite alkyl alcohol with stoichiometric amount of phosphorous oxychloride under Ar in anhydrous CH2Cl2 at reflux for 5 h provided the alkyl dichlorophosphate in a quantitative yield. Derivatives 8 and 9 were prepared by phosphorylation of 4-HPR with alkyl dichlorophosphates in the presence of triethylamine at 0 o C in dry CH 2 Cl 2 and the hydrolysis of the corresponding adduct with H 2 O in good yields.
Anti-proliferative effects of Retinamide derivatives. The growth suppressing potential of retinamide derivatives was investigated by determining their IC 50 values (concentrations giving 50% growth inhibition) in HCT116 colon cancer cells. To determine the IC50 value, each derivative was treated at six different concentrations (0, 0.5, 1, 2.5, 5, 10 µM). As summarized in Table 1 , IC50 of derivative 2 was 1.8 µM, four-fold better than 4-HPR (7.0 µM) in HCT116 cells. IC50 values of other derivatives were slightly better than (derivatives 3, 4, 5, 7), similar to (derivative 1), or much worse than (derivatives 6, 8, 9) that of 4-HPR. For better clinical outcome, we searched for retinoid derivatives with IC 50 of submicromolar concentration and low side effects. Although the IC 50 value of 4-HPR is relatively high, its relatively few side effects made it useful in clinical trial. In this regard, our derivative 2, the most effective agent among the derivatives tested, could be a promising cancer drug, although its side effects remain to be determined by animal studies.
Experimental Section
Dry DMF was stored over 4 Å sieves and degassed before use by bubbling argon vigorously through for at least one hour. Dry CH2Cl2 was obtained from distillation over CaH2. Commercially available reagents and solvents were used without further purification. All reactions were conducted under an Ar atmosphere, except for those reactions utilizing water as a solvent. They were monitored by TLC (Merck Kieselgel 60 F254). All the products prepared were purified by flash column chromatography using silica gel 60 (Merck, 230-400 mesh). 2 Cl 2 (10 mL) was added 2-ketobutyric acid (52.0 mg, 0.510 mmol) in dry CH 2 Cl 2 (5 mL). The solution was stirred at room temperature for 0.5 h. To this mixture were added HPR (100 mg, 0.255 mmol) in dry DMF (2 mL) and DMAP (cat.) and the mixture was stirred for 2-3 h. The reaction was quenched with NH 4 Cl (aq.), and the mixture was subjected to extraction with EtOAc (2 × 5 mL). The extracts were washed with H 2 O and brine, dried (Na 2 SO 4 ), and concentration. The residue was purified by column chromatography using hexane/EtOAc (3/1) as the eluent to give HPR-2-ketobutyrate (60 mg, 50%) as a yellow solid. 2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraenoyl]-amino}phenyl-1-propanesulfonate (6) . To a cold solution of HPR (100 mg, 0.255 mmol) in dry CH2Cl2 (10 mL) and N-methylmorpholine (0.034 mL, 0.306 mmol) was added 1-propane sulfonyl chloride (0.034 mL, 0.306 mmol). After being stirred for 30 min, the mixture was further stirred for 2 h at room temperature. Saturated aqueous NH4Cl was added into the mixture, and the aqueous layer was extracted with EtOAc (2 × 5 mL). The combined organic layers were washed with H2O and brine, dried (Na2SO4), and concentration. 06 (m, 7H), 1.72 (s, 3H), 1.56-1.68 (m, 2H),  1.44-1.49 (m, 2H), 1.10 (t, 3H, ). 2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6 . After being stirred at 0 °C for 1 h, the mixture was refluxed for 5 h, followed by vacuum distillation (bp 38-42°C /0.2 torr) to afford propyl dichlorophosphate.
4-{[(
To a cooled solution of propyl dichlorophosphate (1 eq.) in dry CH 2 Cl 2 (5 mL) were added HPR (0.1 g, 0.33 mmol) in dry CH 2 Cl 2 (5 mL) and triethylamine (0.11 mL, 0.83 mmol). After being stirred for 1 h, H2O (2 mL) was added into the mixture. The mixture was stirred for 2 h at room temperature and quenched with NH4Cl (aq.). The aqueous layer was extracted with CH2Cl2 (2 ×), and the combined organic layers were washed with H2O and brine, dried (Na2SO4), and concentrated. The residue was purified by column chromatography (EtOAc/Hexane = 1 : 2) to afford HPR-propyl phosphate (96 mg, 73%) as a yellow solid. ). Cell proliferation assays. Effects of 4-HPR derivatives on the proliferation of cervical cancer cell were determined using MTT assay kit (Sigma Co., St. Louis, MO) according to the manufacturers manual. Cells were grown in 96 wellmicrotiter plates starting at an initial density of 3 × 10 3 cells/ 100 mL medium/well. After 12 h from seeding, indicated concentrations of derivatives were added to the medium, and the cells were further grown for 48 h. The use of 0.01% DMSO as control of RA, did not affect proliferation of cells tested. After 4 h incubation with MTT reagent, the media was removed. DMSO (150 mL) was added to precipitate and the absorbance at 550 nm was measured using Spectra MAX 250 microplate spectrophotometer (Molecular Devices, Sunnyvale, CA). The results were expressed as mean values of the absorbances of at least four wells.
